{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T11:25:52Z","timestamp":1789212352226,"version":"build-2803163510"},"reference-count":34,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2012,7,24]],"date-time":"2012-07-24T00:00:00Z","timestamp":1343088000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0041457","type":"journal-article","created":{"date-parts":[[2012,7,24]],"date-time":"2012-07-24T21:22:28Z","timestamp":1343164948000},"page":"e41457","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":25,"title":["Development of a Small D-Enantiomeric Alzheimer\u2019s Amyloid-\u03b2 Binding Peptide Ligand for Future In Vivo Imaging Applications"],"prefix":"10.1371","volume":"7","author":[{"given":"Susanne Aileen","family":"Funke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Bartnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian Marius","family":"Gl\u00fcck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kasia","family":"Piorkowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"Wiesehan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Urs","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balazs","family":"Gulyas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christer","family":"Halldin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Pfeifer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Spenger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Muhs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dieter","family":"Willbold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2012,7,24]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.jalz.2007.04.381","article-title":"Forecasting the global burden of Alzheimer\u2019s disease.","volume":"3","author":"R Brookmeyer","year":"2007","journal-title":"Alzheimers & Dementia"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological stageing of Alzheimer-related changes.","volume":"82","author":"H Braak","year":"1991","journal-title":"Acta Neuropathol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0197-4580(97)00056-0","article-title":"Frequency of stages of Alzheimer-related lesions in different age categories.","volume":"18","author":"H Braak","year":"1997","journal-title":"Neurobiol Aging"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/0896-6273(91)90052-2","article-title":"The molecular pathology of Alzheimer\u2019s disease.","volume":"6","author":"DJ Selkoe","year":"1991","journal-title":"Neuron"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/01.wad.0000213881.01289.d9","article-title":"Normal and abnormal tau neurobiology.","volume":"20","author":"K Duff","year":"2006","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0306-4522(01)00169-5","article-title":"The morphological phenotype of beta-amyloid plaques and associated neuritic changes in Alzheimer\u2019s disease.","volume":"105","author":"TC Dickson","year":"2001","journal-title":"Neuroscience"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1212\/01.wnl.0000192107.17175.39","article-title":"Amyloidogenic processing of beta-amyloid precursor protein in intracellular compartments.","volume":"66","author":"KS Vetrivel","year":"2006","journal-title":"Neurology"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nrm2101","article-title":"Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer\u2019s amyloid beta-peptide.","volume":"8","author":"C Haass","year":"2007","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1126\/science.1566067","article-title":"Alzheimer\u2019s disease: the amyloid cascade hypothesis.","volume":"256","author":"JA Hardy","year":"1992","journal-title":"Science"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\u201cMini-mental state\u201d","volume":"12","author":"MF Folstein","year":"1975","journal-title":"J Psychiatr Res"},{"key":"ref11","first-page":"627","article-title":"Alzheimer\u2019s Disease Assessment Scale (ADAS).","volume":"24","author":"RC Mohs","year":"1988","journal-title":"Psychopharmacol Bull"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1111\/j.1532-5415.2004.52459.x","article-title":"Detection and management of cognitive impairment in primary care: The Steel Valley Seniors Survey.","volume":"52","author":"M Ganguli","year":"2004","journal-title":"J Am Geriatr Soc"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1212\/WNL.56.9.1143","article-title":"Practice parameter: diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology.","volume":"56","author":"DS Knopman","year":"2001","journal-title":"Neurology"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1136\/jnnp.2004.047720","article-title":"Do MCI criteria in drug trials accurately identify subjects with predementia Alzheimer\u2019s disease?","volume":"76","author":"PJ Visser","year":"2005","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1212\/01.wnl.0000228230.26044.a4","article-title":"[11C]PIB in a nondemented population: potential antecedent marker of Alzheimer disease.","volume":"67","author":"MA Mintun","year":"2006","journal-title":"Neurology"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.neurobiolaging.2009.04.002","article-title":"Neuropathology of nondemented aging: presumptive evidence for preclinical Alzheimer disease.","volume":"30","author":"JL Price","year":"2009","journal-title":"Neurobiol Aging"},{"key":"ref17","first-page":"594","article-title":"Brain 18F-FDG PET in the diagnosis of neurodegenerative dementias: comparison with perfusion SPECT and with clinical evaluations lacking nuclear imaging.","volume":"45","author":"DH Silverman","year":"2004","journal-title":"J Nucl Med"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1097\/WCO.0b013e3281a47744","article-title":"Amyloid imaging in Alzheimer\u2019s disease.","volume":"20","author":"A Nordberg","year":"2007","journal-title":"Curr Opin Neurol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1016\/j.neuropsychologia.2008.03.020","article-title":"Amyloid imaging in Alzheimer\u2019s disease.","volume":"46","author":"A Nordberg","year":"2008","journal-title":"Neuropsychologia"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/cmdc.200800289","article-title":"In vitro and in vivo staining characteristics of small, fluorescent, Abeta42-binding D-enantiomeric peptides in transgenic AD mouse models.","volume":"4","author":"T van Groen","year":"2009","journal-title":"ChemMedChem"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1093\/protein\/gzm054","article-title":"Inhibition of cytotoxicity and amyloid fibril formation by a D-amino acid peptide that specifically binds to Alzheimer\u2019s disease amyloid peptide.","volume":"21","author":"K Wiesehan","year":"2008","journal-title":"Protein Eng Des Sel"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1002\/cbic.200300570","article-title":"Mirror-image phage display: aiming at the mirror.","volume":"4","author":"K Wiesehan","year":"2003","journal-title":"Chembiochem"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.nucmedbio.2011.09.008","article-title":"Flourine-18 labeling of three novel D-Peptides by conjugation with N-succinimidyl\u20134-[F-18]fluorobenzoate and preliminary examination by post mortem whole hemisphere human brain autoradiography.","volume":"39","author":"NS Jahan M","year":"2012","journal-title":"Nucl Med Bio"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.neuint.2011.10.010","article-title":"Distribution and binding of 18F- labelled and 125I- labelled analogues of ACI-80, a prospective molecular imaging biomarker of disease: a whole hemisphere post mortem autoradiography study in human brains obtained from Alzheimer\u2019s disease patients.","volume":"60","author":"SC Guly\u00e1s B","year":"2012","journal-title":"Neurochem Int"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1089\/rej.2009.0924","article-title":"Differently selected D-enantiomeric peptides act on different Abeta species.","volume":"13","author":"D Bartnik","year":"2010","journal-title":"Rejuvenation Res"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1002\/cmdc.200800273","article-title":"Reduction of Alzheimer\u2019s Disease Amyloid Plaque Load in Transgenic Mice by D3, a D-Enantiomeric Peptide Identified by Mirror Image Phage Display.","volume":"3","author":"T van Groen","year":"2008","journal-title":"ChemMedChem"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ab.2005.09.034","article-title":"Analyzing a kinetic titration series using affinity biosensors.","volume":"349","author":"R Karlsson","year":"2006","journal-title":"Anal Biochem"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1006\/abio.1995.1268","article-title":"Interpreting complex binding kinetics from optical biosensors: a comparison of analysis by linearization, the integrated rate equation, and numerical integration.","volume":"227","author":"TA Morton","year":"1995","journal-title":"Anal Biochem"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"6452","DOI":"10.1523\/JNEUROSCI.20-17-06452.2000","article-title":"Aging increased amyloid peptide and caused amyloid plaques in brain of old APP\/V717I transgenic mice by a different mechanism than mutant presenilin1.","volume":"20","author":"I Dewachter","year":"2000","journal-title":"J Neurosci"},{"key":"ref30","first-page":"181","article-title":"Pyroglutamic acid. Non-metabolic formation, function in proteins and peptides, and characteristics of the enzymes effecting its removal.","author":"GN Abraham","year":"1981"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.neuint.2008.12.016","article-title":"[(11)C]PIB-amyloid binding and levels of Abeta40 and Abeta42 in postmortem brain tissue from Alzheimer patients.","volume":"54","author":"MM Svedberg","year":"2009","journal-title":"Neurochemistry Int"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1126\/science.1604320","article-title":"Total chemical synthesis of a D-enzyme: the enantiomers of HIV-1 protease show reciprocal chiral substrate specificity.","volume":"256","author":"RC Milton","year":"1992","journal-title":"Science"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0002-9440(10)63355-X","article-title":"A synthetic peptide blocking the apolipoprotein E\/beta-amyloid binding mitigates beta-amyloid toxicity and fibril formation in vitro and reduces beta-amyloid plaques in transgenic mice.","volume":"165","author":"M Sadowski","year":"2004","journal-title":"Am J Pathol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1128\/AAC.49.6.2336-2342.2005","article-title":"Human salivary mucin MUC7 12-mer-L and 12-mer-D peptides: antifungal activity in saliva, enhancement of activity with protease inhibitor cocktail or EDTA, and cytotoxicity to human cells.","volume":"49","author":"GX Wei","year":"2005","journal-title":"Antimicrob Agents Chemother"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0041457","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T16:52:05Z","timestamp":1561999925000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0041457"}},"subtitle":[],"editor":[{"given":"Maya","family":"Koronyo-Hamaoui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2012,7,24]]},"references-count":34,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2012,7,24]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0041457","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,7,24]]}}}